s.oyelaran
TL2 Moderator · Setúbal
Contributes reviews on supplier material. Based in Setúbal.
Joined 16 November 2024 · last posted 23h
90 posts, newest first. Showing up to 150.
-
About the Independent verification category Replied, post #6 · Sourcing › Independent verification · 27 Jul 2026 · 17 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #102 · Start Here › Welcome · 23 Jul 2026 · 26 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #83 · Compounds › Retatrutide · 22 Jul 2026 · 0 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #53 · Sourcing › Regulatory · 21 Jul 2026 · 0 likes This follows post #50 rather than contradicting it. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #61 · Clinical › Prescriber conversations · 21 Jul 2026 · 20 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Athletes in weight-category sports: a different risk calculus Replied, post #34 · Clinical › Special populations · 21 Jul 2026 · 18 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #69 · Practice › Dosing & titration · 16 Jul 2026 · 3 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #22 · Evidence › Preprints · 12 Jul 2026 · 0 likes post #21 is right about the mechanism and I think understates the practical bit. Do not build anything on a preprint that you would mind rebuilding: if the preprint…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #89 · Analytics › Home & field testing · 11 Jul 2026 · 17 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
-
What steady state means for the decision to escalate Replied, post #26 · Practice › Dosing & titration · 9 Jul 2026 · 2 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
Fibre intake when total intake falls, and the constipation link — one year on Replied, post #12 · Nutrition & Training › Protein & intake · 8 Jul 2026 · 4 likes This follows post #9 rather than contradicting it. Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #43 · Analytics › Impurities & related substances · 3 Jul 2026 · 25 likes Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a chemical modification that occurs during storage.
-
Journal club: what we got wrong in an earlier session Replied, post #37 · Evidence › Journal club · 28 Jun 2026 · 21 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Electrolyte supplements: which ones do anything Replied, post #37 · Nutrition & Training › Hydration & electrolytes · 22 Jun 2026 · 6 likes Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte depletion. Increasing fluids, salt, and potassium usually resolves…
-
Batch numbers that do not match the vial label Replied, post #30 · Sourcing › Red flags · 16 Jun 2026 · 2 likes This follows post #27 rather than contradicting it. Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way…
-
Revisiting: Liver enzymes drifting down and what that usually means Replied, post #44 · Clinical › Bloodwork · 14 Jun 2026 · 14 likes On post #40 — agreed on the reasoning, with one qualification. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the…
-
Tracking a shortage from primary sources rather than rumour Replied, post #36 · Access › Shortages · 4 Jun 2026 · 14 likes Worth separating two things that post #32 runs together. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply…
-
A site rotation scheme that is easy enough to actually follow Replied, post #72 · Practice › Administration · 26 May 2026 · 24 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #83 · Compounds › Tirzepatide · 24 May 2026 · 0 likes On post #79 — agreed on the reasoning, with one qualification. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy…
-
Revisiting: Patterns that reliably precede a problem, documented Replied, post #4 · Sourcing › Red flags · 19 May 2026 · 7 likes Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
-
The headache that turns out to be dehydration — the long version Replied, post #32 · Nutrition & Training › Hydration & electrolytes · 8 May 2026 · 11 likes Exercise and electrolyte losses: sweating during exercise increases sodium and potassium losses. Electrolyte replacement during or after intense exercise helps maintain…
-
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #28 · Analytics › COA interpretation · 3 May 2026 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #2 · Start Here › How to Ask · 2 May 2026 · 0 likes Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method. Everything else follows from method. A chromatogram without…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #30 · Practice › Administration · 3 Apr 2026 · 0 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
-
Sample handling between despatch and injection Replied, post #13 · Analytics › Method validation · 2 Apr 2026 · 0 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #73 · Clinical › Bloodwork · 31 Mar 2026 · 11 likes This follows post #70 rather than contradicting it. Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #50 · Analytics › Impurities & related substances · 15 Mar 2026 · 18 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #138 · Compounds › Semaglutide · 8 Mar 2026 · 0 likes post #137 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #23 · Evidence › Trials · 7 Mar 2026 · 0 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #84 · Access › International · 31 Jan 2026 · 0 likes I read post #82 twice before replying, because I had assumed the opposite. Customs and import outcomes: different routes have different seizure rates. Some countries…
-
Specification in the result column: why that is a meaningful error Replied, post #109 · Analytics › COA interpretation · 21 Jan 2026 · 12 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #15 · Clinical › Special populations · 21 Jan 2026 · 3 likes Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #65 · Access › International · 20 Jan 2026 · 12 likes Picking up post #62: that is the part I would want checked first. Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #45 · Sourcing › Regulatory · 30 Dec 2025 · 20 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #77 · Compounds › Oral incretins · 23 Dec 2025 · 0 likes This follows post #74 rather than contradicting it. Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a…
-
Tracking a preprint to publication: a worked example Replied, post #130 · Evidence › Preprints · 13 Dec 2025 · 14 likes Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the case that the version appearing in a journal frequently has…
-
Tracking a preprint to publication: a worked example Replied, post #38 · Evidence › Preprints · 3 Dec 2025 · 2 likes Worth separating two things that post #34 runs together. Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also the…
-
What a purity-only report leaves out Replied, post #98 · Sourcing › Independent verification · 22 Nov 2025 · 0 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
[2026 update] What steady state means for the decision to escalate Replied, post #15 · Practice › Dosing & titration · 5 Nov 2025 · 0 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
-
A 40-week log with the measurement method stated Replied, post #70 · Outcomes › Progress reports · 25 Oct 2025 · 10 likes Exercise volume changes: increasing exercise intensity or duration can mask weight loss (muscle gain) on the scale. Noting exercise changes when reporting weight helps…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #126 · Compounds › Tirzepatide · 24 Oct 2025 · 19 likes Picking up post #123: that is the part I would want checked first. Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound…
-
How to read a forest plot, properly, from scratch Replied, post #44 · Evidence › Trials · 22 Oct 2025 · 23 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #15 · Clinical › Special populations · 18 Oct 2025 · 31 likes Picking up post #12: that is the part I would want checked first. Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes…
-
Documentation that appears only after payment Replied, post #51 · Sourcing › Red flags · 17 Oct 2025 · 7 likes post #50 is right about the mechanism and I think understates the practical bit. Unresponsiveness: a supplier that does not reply to reasonable requests for…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #113 · Evidence › Study critique · 16 Sep 2025 · 12 likes On post #109 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Managing an unplanned gap in supply — what changed since Replied, post #58 · Access › Shortages · 9 Sep 2025 · 0 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #32 · Analytics › Method validation · 5 Sep 2025 · 15 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #113 · Practice › Reconstitution · 26 Aug 2025 · 0 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #50 · Practice › Side effects · 24 Aug 2025 · 0 likes Picking up post #47: that is the part I would want checked first. Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals…
-
Publishing an inconvenient result: a case study Replied, post #66 · Sourcing › Independent verification · 14 Aug 2025 · 6 likes On post #62 — agreed on the reasoning, with one qualification. When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #6 · Start Here › How to Ask · 8 Aug 2025 · 31 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #50 · Evidence › Journal club · 8 Aug 2025 · 0 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Which panel is worth repeating and which is worth ignoring Replied, post #79 · Clinical › Bloodwork · 7 Aug 2025 · 3 likes A single value outside interval: usually uninformative on a single draw. What makes a result interesting: a trend across multiple draws, a magnitude well beyond the…
-
Are there stupid questions here? A staff answer, at length Replied, post #47 · Start Here › Welcome · 7 Aug 2025 · 3 likes Worth separating two things that post #43 runs together. Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They…
-
Travel coolers and how long they really hold Replied, post #26 · Devices › Cold chain · 2 Aug 2025 · 0 likes On post #22 — agreed on the reasoning, with one qualification. Freeze-thaw: some peptides tolerate freezing; others do not. Check your compound's labelling. Generally,…
-
Random versus fixed effects: choosing rather than defaulting Replied, post #20 · Evidence › Meta-analyses · 7 Jul 2025 · 0 likes Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest…
-
Repeatability versus intermediate precision Replied, post #91 · Analytics › Method validation · 29 Jun 2025 · 2 likes Picking up post #88: that is the part I would want checked first. Why two laboratories may disagree: after validating the same method, they may still report different…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #53 · Evidence › Journal club · 25 Jun 2025 · 12 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #125 · Compounds › Cagrilintide & amylin analogues · 31 May 2025 · 24 likes Cagrilintide alone is discussed less than in combination because the published data is almost entirely from combination trials. The phase 2 combination data was…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #15 · Clinical › Special populations · 28 May 2025 · 0 likes I read post #13 twice before replying, because I had assumed the opposite. Adolescents: a distinct evidence base exists. The compounds are not approved for routine…
-
Coverage for the indication versus for the drug Replied, post #55 · Access › Insurance & coverage · 6 May 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Certificates issued by the seller versus by a laboratory Replied, post #60 · Analytics › COA interpretation · 24 Apr 2025 · 7 likes Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from reversed-phase purification or acetate after salt exchange. The…
-
Follow-up: Requesting a page: what makes a good request Replied, post #20 · Documentation › Wiki requests · 11 Apr 2025 · 0 likes post #19 is right about the mechanism and I think understates the practical bit. Authority and authorship: if you think a maintained page needs input from someone with…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #36 · Outcomes › Progress reports · 6 Apr 2025 · 0 likes Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #51 · Access › Pricing · 1 Apr 2025 · 4 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Counter-ion content and its effect on measured mass Replied, post #7 · Analytics › Mass spectrometry · 28 Mar 2025 · 21 likes Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect modifications. A simple identity confirmation by…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #30 · Compounds › Tirzepatide · 25 Mar 2025 · 21 likes This follows post #27 rather than contradicting it. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #7 · Evidence › Journal club · 7 Mar 2025 · 23 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
What a 2 ppm match establishes, and what it does not Replied, post #3 · Analytics › Mass spectrometry · 28 Feb 2025 · 22 likes This follows post #2 rather than contradicting it. Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #52 · Sourcing › Red flags · 14 Feb 2025 · 26 likes This follows post #49 rather than contradicting it. Anonymity: a supplier that will not disclose legal name, address, or responsible person is not operating in a way…
-
UK access routes, dated and sourced — a second dataset Replied, post #37 · Regional › UK & Ireland · 10 Feb 2025 · 19 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
-
Protein density versus volume when you cannot eat much Replied, post #105 · Nutrition & Training › Protein & intake · 10 Feb 2025 · 12 likes I read post #103 twice before replying, because I had assumed the opposite. Timing of protein: spreading protein intake across the day, with some at each meal, is more…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #34 · Evidence › Meta-analyses · 1 Feb 2025 · 6 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
-
What we do not know about retatrutide, listed explicitly Replied, post #68 · Compounds › Retatrutide · 24 Jan 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #45 · Compounds › Oral incretins · 13 Jan 2025 · 31 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
-
Second pass at: Historical amylin analogues and what happened to them Replied, post #9 · Compounds › Cagrilintide & amylin analogues · 11 Jan 2025 · 0 likes Coming back to post #7, because the follow-up matters more than the original answer. Is synergy the right word for the combination data? A phase 2 trial cannot…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #3 · Compounds › Repair & healing peptides · 1 Jan 2025 · 24 likes post #2 is right about the mechanism and I think understates the practical bit. Oral versus injected administration claims for BPC-157: the preclinical work studied…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #94 · Compounds › Semaglutide · 24 Dec 2024 · 4 likes post #93 is right about the mechanism and I think understates the practical bit. Approved indications differ by jurisdiction and change. As of mid-2026 the…
-
Washout with a one-week half-life: the arithmetic Replied, post #21 · Research Methods › N-of-1 designs · 26 Nov 2024 · 0 likes Coming back to post #19, because the follow-up matters more than the original answer. Designing a personal experiment that could actually change your mind: that is the…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #43 · Compounds › Tirzepatide · 18 Nov 2024 · 1 like Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Time to steady state after a dose increase Replied, post #96 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 11 likes Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to…
-
Blind submission and why it changes minds Replied, post #97 · Sourcing › Independent verification · 24 Oct 2024 · 26 likes post #96 is right about the mechanism and I think understates the practical bit. Service differences on vendor pages: Janoshik and Medutest results are measurements on…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #20 · Wellbeing › Mental health · 7 Oct 2024 · 2 likes Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment.
-
Why I ask for the gradient before I discuss the number Replied, post #17 · Analytics › HPLC & UHPLC · 1 Sep 2024 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
High-resolution MS on aggregates and what it can see — one year on Replied, post #38 · Analytics › Mass spectrometry · 17 Aug 2024 · 4 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
The mass-error checker and its intended scope Replied, post #154 · Data & Tools › Calculators · 26 Jul 2024 · 22 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #84 · Compounds › Retatrutide · 22 Jul 2024 · 25 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #13 · Practice › Dosing & titration · 6 Jul 2024 · 18 likes On post #9 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you…
-
The mass-error checker and its intended scope Replied, post #91 · Data & Tools › Calculators · 2 Jul 2024 · 0 likes post #90 is right about the mechanism and I think understates the practical bit. Mass error checking: enter your observed mass and theoretical mass and check whether…
-
Cold packs, phase-change material, and what survives ten days Replied, post #3 · Sourcing › Logistics · 8 Jun 2024 · 2 likes Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research chemical, 5 grams" is better than "vitamin" or "other"…